$Eleven Bi_老虎社区_美港股上老虎 - 老虎社区

$Eleven Biotherapeutics Inc.(EBIO)$Vicinium一期、二期临床试验数据十分乐观。FDA在今年2月份发布的相关指引也显示，Eleven Bio的三期临床试验设计方案非常符合指引中的建议。

该公司将在5月21日召开的美国泌尿学会大会上公布首批75名患者的试验数据，并将在6月下旬公布完整的试验数据。“主要终点”数据则可能在2019年3月底公布。 Vicinium预计会在2019年底至2020年初获得批准。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

TAB大小写
2018-05-09
TAB大小写
一期二期数据十分乐观，“十分”两个字哪里得来的？二期和临床意义6月和12月数据相比有效数值还差一点
- chase nature回复ScottS:
  从我药学专业角度看75人的临床数据肯定是不够的，这次75人的数据就算还行也并不一定代表这个药一定能成功上市
- ScottS:
  是否有更详细的分析，以及你的估值预期? 只看他的一篇文章肯定不够。。。
ScottS
2018-05-11
ScottS
打算在5-21前不管如何涨跌都不抛了。反正也没投多少钱。
ScottS
2018-05-09
ScottS
转载原文请搜索《一只可能暴跌50%或暴涨2000%的生物医药股》
- 小黑馬:
  我也是看见这个买的
意境深渊之
2018-05-09
意境深渊之
嗯
ScottS
2018-05-09
ScottS
转载的

发表看法

8

1

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":185910,"tweetId":"185910","gmtCreate":1525862729123,"gmtModify":1704892702659,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"authorIdStr":"3467930283919797","name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>$Eleven Biotherapeutics Inc.(EBIO)$Vicinium一期、二期临床试验数据十分乐观。FDA在今年2月份发布的相关指引也显示，Eleven Bio的三期临床试验设计方案非常符合指引中的建议。</p> 该公司将在5月21日召开的美国泌尿学会大会上公布首批75名患者的试验数据，并将在6月下旬公布完整的试验数据。“主要终点”数据则可能在2019年3月底公布。 Vicinium预计会在2019年底至2020年初获得批准。</body></html>","htmlText":"<html><head></head><body><p>$Eleven Biotherapeutics Inc.(EBIO)$Vicinium一期、二期临床试验数据十分乐观。FDA在今年2月份发布的相关指引也显示，Eleven Bio的三期临床试验设计方案非常符合指引中的建议。</p> 该公司将在5月21日召开的美国泌尿学会大会上公布首批75名患者的试验数据，并将在6月下旬公布完整的试验数据。“主要终点”数据则可能在2019年3月底公布。 Vicinium预计会在2019年底至2020年初获得批准。</body></html>","text":"$Eleven Biotherapeutics Inc.(EBIO)$Vicinium一期、二期临床试验数据十分乐观。FDA在今年2月份发布的相关指引也显示，Eleven Bio的三期临床试验设计方案非常符合指引中的建议。 该公司将在5月21日召开的美国泌尿学会大会上公布首批75名患者的试验数据，并将在6月下旬公布完整的试验数据。“主要终点”数据则可能在2019年3月底公布。 Vicinium预计会在2019年底至2020年初获得批准。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":8,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/185910","repostId":0,"isVote":1,"tweetType":1,"viewCount":3809,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["EBIO"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":339,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":747837,"commentId":"747837","gmtCreate":1525880683667,"gmtModify":1525880683667,"authorId":143785433098692,"author":{"id":143785433098692,"idStr":"143785433098692","authorId":143785433098692,"name":"TAB大小写","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":185910,"objectIdStr":"185910","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"一期二期数据十分乐观，“十分”两个字哪里得来的？二期和临床意义6月和12月数据相比有效数值还差一点","text":"一期二期数据十分乐观，“十分”两个字哪里得来的？二期和临床意义6月和12月数据相比有效数值还差一点","html":"一期二期数据十分乐观，“十分”两个字哪里得来的？二期和临床意义6月和12月数据相比有效数值还差一点","likeSize":0,"commentSize":2,"subComments":[{"id":748713,"commentId":"748713","gmtCreate":1525944195275,"gmtModify":1525944195275,"authorId":3482126431594558,"author":{"id":3482126431594558,"idStr":"3482126431594558","authorId":3482126431594558,"name":"chase nature","avatar":"https://static.tigerbbs.com/df8c951e972c73a356d50beeb0ed5ebb","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":3467930283919797,"repliedAuthor":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"objectId":185910,"objectIdStr":"185910","type":1,"supId":747837,"supIdStr":"747837","prevId":748638,"prevIdStr":"748638","content":"从我药学专业角度看75人的临床数据肯定是不够的，这次75人的数据就算还行也并不一定代表这个药一定能成功上市","text":"从我药学专业角度看75人的临床数据肯定是不够的，这次75人的数据就算还行也并不一定代表这个药一定能成功上市","html":"从我药学专业角度看75人的临床数据肯定是不够的，这次75人的数据就算还行也并不一定代表这个药一定能成功上市","disclaimerType":0},{"id":748638,"commentId":"748638","gmtCreate":1525939660184,"gmtModify":1525939660184,"authorId":3467930283919797,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":185910,"objectIdStr":"185910","type":1,"supId":747837,"supIdStr":"747837","prevId":0,"prevIdStr":"0","content":"是否有更详细的分析，以及你的估值预期? 只看他的一篇文章肯定不够。。。","text":"是否有更详细的分析，以及你的估值预期? 只看他的一篇文章肯定不够。。。","html":"是否有更详细的分析，以及你的估值预期? 只看他的一篇文章肯定不够。。。","disclaimerType":0}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":750275,"commentId":"750275","gmtCreate":1525993852977,"gmtModify":1525993852977,"authorId":3467930283919797,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":185910,"objectIdStr":"185910","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"打算在5-21前不管如何涨跌都不抛了。反正也没投多少钱。","text":"打算在5-21前不管如何涨跌都不抛了。反正也没投多少钱。","html":"打算在5-21前不管如何涨跌都不抛了。反正也没投多少钱。","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":747180,"commentId":"747180","gmtCreate":1525872232613,"gmtModify":1525872232613,"authorId":3467930283919797,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":185910,"objectIdStr":"185910","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"转载原文请搜索《一只可能暴跌50%或暴涨2000%的生物医药股》","text":"转载原文请搜索《一只可能暴跌50%或暴涨2000%的生物医药股》","html":"转载原文请搜索《一只可能暴跌50%或暴涨2000%的生物医药股》","likeSize":0,"commentSize":1,"subComments":[{"id":749772,"commentId":"749772","gmtCreate":1525968101181,"gmtModify":1525968101181,"authorId":3459712649056184,"author":{"id":3459712649056184,"idStr":"3459712649056184","authorId":3459712649056184,"name":"小黑馬","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":185910,"objectIdStr":"185910","type":1,"supId":747180,"supIdStr":"747180","prevId":0,"prevIdStr":"0","content":"我也是看见这个买的","text":"我也是看见这个买的","html":"我也是看见这个买的","disclaimerType":0}],"verified":10,"allocateAmount":0,"commentType":"valid","coins":0,"score":0,"disclaimerType":0},{"id":746913,"commentId":"746913","gmtCreate":1525865272374,"gmtModify":1525865272374,"authorId":3479274777954075,"author":{"id":3479274777954075,"idStr":"3479274777954075","authorId":3479274777954075,"name":"意境深渊之","avatar":"https://static.laohu8.com/picture109","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":185910,"objectIdStr":"185910","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"嗯","text":"嗯","html":"嗯","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0},{"id":746717,"commentId":"746717","gmtCreate":1525862890936,"gmtModify":1525862890936,"authorId":3467930283919797,"author":{"id":3467930283919797,"idStr":"3467930283919797","authorId":3467930283919797,"name":"ScottS","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":185910,"objectIdStr":"185910","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"转载的","text":"转载的","html":"转载的","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0,"disclaimerType":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/185910"}